Loading…
avatar for Nicole Schlautmann

Nicole Schlautmann

Pfizer Pharma
General Manager
Nicole Schlautmann, since 2016 General Manager of Pfizer Pharma GmbH is leading the Rare Disease business unit. Indications in this area include endocrinology, hemophilia, transplantation and neurology. The ongoing digitization and growing importance of e-health solutions inspires and motivates the team around Nicole Schlautmann to a great extent. Rare diseases often have a severe course of disease and accompany the patients for a lifetime. Digital tools and services can provide tremendous added value create solutions for those affected and their families. Pfizer has already successfully implemented two Healthcare Apps in the area of Rare Diseases. "GroAssist" is an app that supports children with a growth disorder, their parents and the attending physician in carrying out growth hormone therapy. "Haemoassist 2" is an app and web-based therapy diary for hemophilia patients with web access for the attending physician. In the field of hemophilia, Pfizer is also currently working in Germany on the implementation of the digital educational game for children and adolescents "Hemo-Heroes".